Fig. 1

Schema. IA: idarubicin + cytarabine; DA: daunorubicin + cytarabine; CR: complete response; CRi: CR with incomplete blood cell count recovery; NR: no response; PR: partial remission.

Schema. IA: idarubicin + cytarabine; DA: daunorubicin + cytarabine; CR: complete response; CRi: CR with incomplete blood cell count recovery; NR: no response; PR: partial remission.